Niewold Timothy B, Adler Jeremy E, Glenn Stuart B, Lehman Thomas J A, Harley John B, Crow Mary K
Section of Rheumatology, University of Chicago, Chicago, Illinois 60637, USA.
Arthritis Rheum. 2008 Jul;58(7):2113-9. doi: 10.1002/art.23619.
Interferon-alpha (IFNalpha) levels are elevated in many patients with systemic lupus erythematosus (SLE) and may play a primary role in its pathogenesis. The purpose of this study was to determine whether serum IFNalpha activity in SLE patients and their healthy first-degree relatives is highest in early adulthood, when the incidence of SLE is greatest.
Serum samples from 315 SLE patients, 359 healthy first-degree relatives, and 141 healthy unrelated donors were measured for IFNalpha activity using a functional reporter cell assay. IFNalpha activity was analyzed in relation to age, and subgroups with high levels of IFNalpha activity were identified within the large data sets using a Mann-Whitney sliding window segmentation algorithm. The significance of each subgrouping was ranked by Kruskal-Wallis testing.
Age was inversely correlated with IFNalpha activity in female SLE patients (r = -0.20, P = 0.001) as well as their healthy female first-degree relatives (r = -0.16, P = 0.02). In male patients and their healthy male first-degree relatives, there was no significant overall correlation between age and serum IFNalpha activity. The segmentation algorithm revealed significantly increased IFNalpha activity between the ages of 12 and 22 years in female SLE patients and between the ages of 16 and 29 years in male SLE patients. Both male and female healthy first-degree relatives had significantly decreased IFNalpha activity after the age of 50 years.
Serum IFNalpha activity is higher in younger individuals in the SLE family cohorts, and this tendency is accentuated in affected individuals. This age-related pattern of IFNalpha activity may contribute to the increased incidence of SLE in early adulthood, and interestingly, males and females had similar age-related patterns of IFNalpha activity.
许多系统性红斑狼疮(SLE)患者体内的α干扰素(IFNα)水平升高,其可能在SLE发病机制中起主要作用。本研究旨在确定SLE患者及其健康的一级亲属的血清IFNα活性在SLE发病率最高的成年早期是否最高。
使用功能性报告细胞分析法检测了315例SLE患者、359例健康一级亲属和141例健康非亲属供者的血清样本中的IFNα活性。分析IFNα活性与年龄的关系,并使用Mann-Whitney滑动窗口分割算法在大数据集中识别出IFNα活性水平较高的亚组。通过Kruskal-Wallis检验对每个亚组划分的显著性进行排序。
女性SLE患者(r = -0.20,P = 0.001)及其健康的女性一级亲属(r = -0.16,P = 0.02)中,年龄与IFNα活性呈负相关。在男性患者及其健康的男性一级亲属中,年龄与血清IFNα活性之间无显著的总体相关性。分割算法显示,女性SLE患者在12至22岁之间、男性SLE患者在16至29岁之间IFNα活性显著增加。男性和女性健康的一级亲属在50岁以后IFNα活性均显著降低。
SLE家系队列中较年轻个体的血清IFNα活性较高,且这种趋势在患病个体中更为明显。这种与年龄相关的IFNα活性模式可能导致成年早期SLE发病率增加,有趣的是,男性和女性的IFNα活性与年龄相关的模式相似。